ID   CDK20_HUMAN             Reviewed;         346 AA.
AC   Q8IZL9; A2A389; A2A390; B4DQX1; O95137; Q5EDC4; Q5VYW1; Q9BUF4;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   15-MAR-2017, entry version 131.
DE   RecName: Full=Cyclin-dependent kinase 20;
DE            EC=2.7.11.22;
DE   AltName: Full=CDK-activating kinase p42;
DE            Short=CAK-kinase p42;
DE   AltName: Full=Cell cycle-related kinase;
DE   AltName: Full=Cell division protein kinase 20;
DE   AltName: Full=Cyclin-dependent protein kinase H;
DE   AltName: Full=Cyclin-kinase-activating kinase p42;
GN   Name=CDK20; Synonyms=CCRK, CDCH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Jiang Y., Zhao K.;
RL   Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Chen J.H., Luo W.Q., Hu S.N., Huang X.W., Tan X.Y., Yuan J.G.,
RA   Qiang B.Q.;
RT   "Cloning a cyclin-dependent protein kinase CDCH.";
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Heart;
RA   Qiu H., Depre C.;
RT   "Cardiac CCRK splice variant.";
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LEU-86; THR-137 AND
RP   ARG-281.
RG   NIEHS SNPs program;
RL   Submitted (SEP-2002) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   FUNCTION, SUBUNIT, SUBCELLULAR LOCATION, AND MUTAGENESIS OF THR-161.
RX   PubMed=14597612; DOI=10.1074/jbc.M309995200;
RA   Liu Y., Wu C., Galaktionov K.;
RT   "p42, a novel cyclin-dependent kinase-activating kinase in mammalian
RT   cells.";
RL   J. Biol. Chem. 279:4507-4514(2004).
RN   [10]
RP   INTERACTION WITH MAK.
RX   PubMed=21986944; DOI=10.1038/onc.2011.464;
RA   Wang L.Y., Kung H.J.;
RT   "Male germ cell-associated kinase is overexpressed in prostate cancer
RT   cells and causes mitotic defects via deregulation of APC/C(CDH1).";
RL   Oncogene 31:2907-2918(2012).
RN   [11]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-106.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Required for high-level Shh responses in the developing
CC       neural tube. Together with TBC1D32, controls the structure of the
CC       primary cilium by coordinating assembly of the ciliary membrane
CC       and axoneme, allowing GLI2 to be properly activated in response to
CC       SHH signaling (By similarity). Involved in cell growth. Activates
CC       CDK2, a kinase involved in the control of the cell cycle, by
CC       phosphorylating residue 'Thr-160'. {ECO:0000250,
CC       ECO:0000269|PubMed:14597612}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Monomer. Interacts with TBC1D32 (By similarity).
CC       Interacts with MAK. {ECO:0000250, ECO:0000269|PubMed:14597612,
CC       ECO:0000269|PubMed:21986944}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14597612}.
CC       Cytoplasm {ECO:0000250}. Cell projection, cilium {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q8IZL9-1; Sequence=Displayed;
CC       Name=2; Synonyms=Cardiac CCRK;
CC         IsoId=Q8IZL9-2; Sequence=VSP_016748, VSP_016750;
CC       Name=3;
CC         IsoId=Q8IZL9-3; Sequence=VSP_016749, VSP_016751, VSP_016752;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=Q8IZL9-4; Sequence=VSP_043294, VSP_016749;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=Q8IZL9-5; Sequence=VSP_016749;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC98920.1; Type=Frameshift; Positions=331; Evidence={ECO:0000305};
CC       Sequence=CAH72843.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/ccrk/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CCRKID43196ch9q22.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF035013; AAC98920.1; ALT_FRAME; mRNA.
DR   EMBL; AF113130; AAF43778.1; -; mRNA.
DR   EMBL; AY904367; AAW82349.1; -; mRNA.
DR   EMBL; AF547664; AAN28684.1; -; Genomic_DNA.
DR   EMBL; AK075325; BAG52110.1; -; mRNA.
DR   EMBL; AK298993; BAG61083.1; -; mRNA.
DR   EMBL; AL353572; CAH72843.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL353572; CAM17657.1; -; Genomic_DNA.
DR   EMBL; AL353572; CAM17658.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62746.1; -; Genomic_DNA.
DR   EMBL; CH471089; EAW62748.1; -; Genomic_DNA.
DR   EMBL; BC002655; AAH02655.1; -; mRNA.
DR   CCDS; CCDS35060.1; -. [Q8IZL9-1]
DR   CCDS; CCDS55324.1; -. [Q8IZL9-2]
DR   CCDS; CCDS65075.1; -. [Q8IZL9-3]
DR   CCDS; CCDS6677.1; -. [Q8IZL9-5]
DR   CCDS; CCDS6678.1; -. [Q8IZL9-4]
DR   RefSeq; NP_001034892.1; NM_001039803.2. [Q8IZL9-1]
DR   RefSeq; NP_001164110.1; NM_001170639.1. [Q8IZL9-3]
DR   RefSeq; NP_001164111.1; NM_001170640.1. [Q8IZL9-2]
DR   RefSeq; NP_036251.2; NM_012119.4. [Q8IZL9-5]
DR   RefSeq; NP_848519.1; NM_178432.3. [Q8IZL9-4]
DR   UniGene; Hs.522274; -.
DR   ProteinModelPortal; Q8IZL9; -.
DR   SMR; Q8IZL9; -.
DR   BioGrid; 117096; 35.
DR   IntAct; Q8IZL9; 20.
DR   STRING; 9606.ENSP00000322343; -.
DR   ChEMBL; CHEMBL3559691; -.
DR   iPTMnet; Q8IZL9; -.
DR   PhosphoSitePlus; Q8IZL9; -.
DR   BioMuta; CDK20; -.
DR   DMDM; 74759739; -.
DR   MaxQB; Q8IZL9; -.
DR   PaxDb; Q8IZL9; -.
DR   PeptideAtlas; Q8IZL9; -.
DR   PRIDE; Q8IZL9; -.
DR   Ensembl; ENST00000325303; ENSP00000322343; ENSG00000156345. [Q8IZL9-1]
DR   Ensembl; ENST00000336654; ENSP00000338975; ENSG00000156345. [Q8IZL9-4]
DR   Ensembl; ENST00000375871; ENSP00000365031; ENSG00000156345. [Q8IZL9-2]
DR   Ensembl; ENST00000375883; ENSP00000365043; ENSG00000156345. [Q8IZL9-5]
DR   Ensembl; ENST00000605159; ENSP00000474485; ENSG00000156345. [Q8IZL9-3]
DR   GeneID; 23552; -.
DR   KEGG; hsa:23552; -.
DR   UCSC; uc004apr.4; human. [Q8IZL9-1]
DR   CTD; 23552; -.
DR   DisGeNET; 23552; -.
DR   GeneCards; CDK20; -.
DR   HGNC; HGNC:21420; CDK20.
DR   HPA; HPA007666; -.
DR   HPA; HPA027379; -.
DR   HPA; HPA027401; -.
DR   MIM; 610076; gene.
DR   neXtProt; NX_Q8IZL9; -.
DR   OpenTargets; ENSG00000156345; -.
DR   PharmGKB; PA165585688; -.
DR   eggNOG; KOG0659; Eukaryota.
DR   eggNOG; ENOG410XQDH; LUCA.
DR   GeneTree; ENSGT00830000128262; -.
DR   HOGENOM; HOG000233024; -.
DR   HOVERGEN; HBG014652; -.
DR   InParanoid; Q8IZL9; -.
DR   KO; K08817; -.
DR   OMA; KAKHIET; -.
DR   OrthoDB; EOG091G0CI9; -.
DR   PhylomeDB; Q8IZL9; -.
DR   TreeFam; TF327240; -.
DR   SignaLink; Q8IZL9; -.
DR   SIGNOR; Q8IZL9; -.
DR   ChiTaRS; CDK20; human.
DR   GenomeRNAi; 23552; -.
DR   PRO; PR:Q8IZL9; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000156345; -.
DR   CleanEx; HS_CCRK; -.
DR   ExpressionAtlas; Q8IZL9; baseline and differential.
DR   Genevisible; Q8IZL9; HS.
DR   GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019912; F:cyclin-dependent protein kinase activating kinase activity; IBA:GO_Central.
DR   GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:1904031; P:positive regulation of cyclin-dependent protein kinase activity; IBA:GO_Central.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell cycle; Cell division;
KW   Cell projection; Cilium; Complete proteome; Cytoplasm;
KW   Developmental protein; Kinase; Nucleotide-binding; Nucleus;
KW   Polymorphism; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN         1    346       Cyclin-dependent kinase 20.
FT                                /FTId=PRO_0000085701.
FT   DOMAIN        4    288       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      10     18       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    127    127       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      33     33       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VAR_SEQ      25     25       E -> EPRVGWQCLPSILQ (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043294.
FT   VAR_SEQ     168    243       WYRAPELLYGARQYDQGVDLWSVGCIMGELLNGSPLFPGKN
FT                                DIEQLCYVLRILGTPNPQVWPELTELPDYNKISFK -> SS
FT                                LSCRTTTRSPLRSRCPCPWRRCCLTSLPRHWICWVNSFSTL
FT                                LTSASQLPRLSSISTSSQLPCLPIHLSCRFLSV (in
FT                                isoform 2). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_016748.
FT   VAR_SEQ     168    188       Missing (in isoform 3, isoform 4 and
FT                                isoform 5). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.1, ECO:0000303|Ref.2}.
FT                                /FTId=VSP_016749.
FT   VAR_SEQ     244    346       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_016750.
FT   VAR_SEQ     282    296       ALLHQYFFTAPLPAH -> LPCLPIHLSCRFLSV (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016751.
FT   VAR_SEQ     297    346       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_016752.
FT   VARIANT      86     86       S -> L (in dbSNP:rs28364953).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_024762.
FT   VARIANT     106    106       S -> N (in dbSNP:rs41286029).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041957.
FT   VARIANT     137    137       A -> T (in dbSNP:rs28364955).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_024763.
FT   VARIANT     281    281       K -> R (in dbSNP:rs28364963).
FT                                {ECO:0000269|Ref.4}.
FT                                /FTId=VAR_024764.
FT   MUTAGEN     161    161       T->A: Impairs CDK2 T-160 phosphorylation
FT                                and activity.
FT                                {ECO:0000269|PubMed:14597612}.
FT   CONFLICT     30     30       V -> I (in Ref. 1; AAC98920 and 2;
FT                                AAF43778). {ECO:0000305}.
SQ   SEQUENCE   346 AA;  38695 MW;  EB6A53E97301D5AE CRC64;
     MDQYCILGRI GEGAHGIVFK AKHVETGEIV ALKKVALRRL EDGFPNQALR EIKALQEMED
     NQYVVQLKAV FPHGGGFVLA FEFMLSDLAE VVRHAQRPLA QAQVKSYLQM LLKGVAFCHA
     NNIVHRDLKP ANLLISASGQ LKIADFGLAR VFSPDGSRLY THQVATRWYR APELLYGARQ
     YDQGVDLWSV GCIMGELLNG SPLFPGKNDI EQLCYVLRIL GTPNPQVWPE LTELPDYNKI
     SFKEQVPMPL EEVLPDVSPQ ALDLLGQFLL YPPHQRIAAS KALLHQYFFT APLPAHPSEL
     PIPQRLGGPA PKAHPGPPHI HDFHVDRPLE ESLLNPELIR PFILEG
//
